Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v3-EN
Language French English
Date Updated 2019-02-21 2018-10-11
Drug Identification Number 02263866 02263866
Brand name ACT ETIDROCAL ACT ETIDROCAL
Common or Proper name ETIDROCAL ETIDROCAL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ETIDRONATE DISODIUM CALCIUM ETIDRONATE DISODIUM CALCIUM
Strength(s) 400MG 500MG 400MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90 90
ATC code M05BB M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-01 2018-05-01
Estimated end date Unknown 2018-10-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments